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WHAT THIS PAPER ADDS
 Endovascular repair (TEVAR) can reduce the perioperative risks associated with treatment of chronic type B dissection (CD), but
remains controversial. This analysis presents one of the largest series of TEVAR for CD, (58 patients treated 2000e2010). Despite
acceptable perioperative mortality, mid-term outcome was discouraging with reduction of aortic diameter in only 50% of the
patients. Mid-term survival was higher in patients with aortic remodelling, which occurred with extensive false lumen thrombosis.
Further optimisation of treatment strategies in CD is needed to achieve full depressurisation of the false lumena r t i c l e i n f o
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Objectives: To assess the durability of endovascular repair (TEVAR) in chronic type B dissection (CD) and
identify factors predictive of outcome.
Design: Retrospective analysis of a prospective database.
Materials: Patients undergoing TEVAR for CD at a tertiary referral centre 2000e2010.
Methods: Analysis of pre-operative characteristics, operative outcome, false lumen thrombosis, aortic
diameter and survival.
Results: 58 consecutive patients were included (49 elective, 9 urgent, mean age 66 years). Mean aortic
diameter was 6.4 cm (Standard deviation SD 1.3 cm). Three patients died perioperatively (5%, 1 urgent, 2
elective). Complications included retrograde type A dissection (n ¼ 3), paraplegia (1), and transient
ischaemic attack (1). Estimated survival (KaplaneMeier) was 89% (1-year) and 64% (3-years). Forty-seven
patients had mid-term imaging follow-up at mean 38 months. Reintervention rate was 15% at 1-year and
29% at 3-years. Aortic diameter decreased in 24, was stable in 15 and increased in 8. Mid-term survival
was higher in patients with aortic remodelling (reduction of aortic diameter >0.5 cm; 3-year 89%) than
without (54%; Log Rank p ¼ 0.005). Remodelling occurred with extensive false lumen thrombosis.
Conclusion: Satisfactory mid-term outcome after TEVAR for CD remains a challenge. Survival is associated
with aortic remodelling, which is related to persistence of ﬂow in the false lumen.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Traditionally, patients with aortic dilatation due to chronic type B
dissection are offered open thoracic or thoracoabdominal aortic repairascular Surgery, Guy’s and St
Road, London SE1 7EH, UK.
i).
ciety for Vascular Surgery. Publishto prevent rupture.1 However, open surgery carries a signiﬁcant risk of
mortality andmorbidity,1e3 and endovascular repair has the potential
to reduce the risks associated with treatment.4 Endovascular treat-
ment for chronic dissection involves covering the primary entry tear
with a stentgraft which depressurises the false lumen resulting in
a decrease in aortic diameter and a reduced risk of rupture. The
presence of a rigid dissection ﬂap and multiple entry tears could
adversely affect the success of endovascular treatment of chronic typeed by Elsevier Ltd. All rights reserved.
K. Mani et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 386e391 387B aortic dissection. Currently, the data on endovascular treatment of
chronic type B dissections are primarily from institutional reports and
registries,5e10 which often report results in mixed groups of
patients.5,9 Themid- to long-termsuccessof endovascular repair is still
debated.5 The aimof intervention is to avoid death fromaortic rupture
but success is oftenmeasuredwith surrogate imagingmarkers such as
aortic diameter or false lumen thrombosis.5,10 The accuracy of these
factors in predicting success in terms of survival is not known.
Endovascular treatment has been the primary management of
complicated chronic type B dissection at our centre since 2000. In
this report, the short- and mid-term outcomes of endovascular
repair of chronic type B dissections at a tertiary referral centre over
the past decade were analysed. The immediate and late complica-
tions, short- and mid-term survival, false lumen thrombosis and
changes in aortic diameter were evaluated to identify factors
predictive of outcome.
Materials and Methods
All patientswhounderwent endovascular stentgraft treatment for
chronic (>14days1) StanfordTypeBdissectionAugust 2000 toAugust
2010 at a tertiary referral centre for aortic pathology were identiﬁed
from a local prospective registry of thoracic endovascular aortic
repairs. Patient characteristics, morphology of the aortic dissection,
operative details, perioperative outcome and re-interventions during
follow-up were recorded prospectively. Measurements of the
descending aortic diameter at the site of maximum dilatation were
performed on axial preoperative and follow-up CT images and
recorded prospectively in the database. Change in the maximum
diameter of the descending thoracic aorta, and the presence of
contrast within the false lumen at the proximal, mid and distal extent
of the stentgraft and distal to the device were recorded, Fig. 1. These
levels are theanatomicalequivalent fora classic typeBdissectionwithFigure 1. Computed tomography (CT) images of Type IIIA chronic type B dissection
prior to stentgraft treatment (A and B) with entry tear in descending aorta, false lumen
perfusion and dilatation (*). After stentgraft treatment (C and D), false lumen is
thrombosed (assessed as lack of contrast enhancement on arterial phase CT) and the
maximum descending aortic diameter is reduced by 10 mm.the entry tear distal to the left subclavian artery: 2 cmdistal to the left
subclavian artery, bifurcation of the pulmonary artery, distal
descending aorta and abdominal aorta. Datawere primarily obtained
from the registry and were conﬁrmed when necessary by review of
patient records and imaging. Cause of death was recorded where
possible based on in-hospital and primary care medical records.
Analyses of data were performed retrospectively. Pre-operative
characteristics and peri-operative outcome as well as post-
operative interventions were assessed. False lumen thrombosis
(deﬁned as lack of contrast enhancement in the false lumen during
arterial phase CT imaging), change in maximum descending aortic
diameter, and mortality were assessed as outcome measures.
Survival was assessed for the full cohort, as well as separately for
patients with aortic remodelling (>0.5 cm reduction in maximum
descending aortic diameter from pre-operative imaging to ﬁnal
follow-up) compared to those with no remodelling. The threshold
level of >0.5 cm diameter reduction was chosen to accommodate
for inter-measurement variability and potential cardiac phase
variations in the descending aortic diameter.11
Treatment algorithm
Indications for treatment of chronic type B dissection were
aneurysmal dilatation of the aorta >5.5 cm, rapid expansion of
>1 cm in one year, or symptomatic disease (i.e. leaking aneurysm or
back and chest pain with aortic dilatation). Preoperative imaging
consisted of computed tomography (CT) angiography and intra-
arterial digital subtraction angiography when indicated for assess-
ment of entry tears and ﬂow from the true and false lumens into the
visceral and renal arteries. The aim of treatment was to depressurise
the aneurysmal segment of the false lumen by covering the primary
entry tear. The stentgraft was oversized by 5e15%. relative to the
diameter of the undissected aorta proximal to the type B dissection
andwas irrespective of any diameter change of the distal true lumen.
A landing zone of >2 cm proximal and distal to the primary entry
tear was regarded as the minimum required. Revascularisation of
supra-aortic vessels with proximal vessel ligation or coil embolisa-
tion was performed as a staged procedure in haemodynamically
stable patients before stentgraft insertion in all cases where the left
common carotid artery was planned to be covered by the device, and
selectively with the left subclavian artery.12All procedures were
performed in a hybrid operating theatre. The position of the sten-
tgraft in the true lumen was assessed with peri-operative angiog-
raphy. Balloon dilatation of the devicewas never used due to the risk
of acute retrograde aortic dissection.13 The majority of procedures
were performed under loco-regional anaesthesia. Prophylactic
spinal drain insertion was considered if the procedure was per-
formed under general anaesthetic (due to the lack of possibility of
perioperative neurological assessment), planned long segment
coverage (the descending thoracic aorta from proximal to the left
subclavian to the coeliac axis), deliberate occlusion of the left
subclavian artery without revascularisation, extensive disease or
occlusion of the internal iliac arteries, and/or previous infra-renal
aortic repair. Follow-up with contrast enhanced CT imaging was
performed at 3 months and yearly post intervention. CT examina-
tions were performed with pre-contrast and non-cardiac gated
arterial phase contrast-enhanced helical scanners with 1e5 mm
thick axial slices reconstructed on a computer workstation.
Statistical analysis
Continuous variables were described as mean and standard
deviation (SD) if normally distributed as assessed with histograms
and otherwise with medians and inter-quartile range (IQR). Inde-
pendent samples t-test was used for comparison of normally
Table 2
Perioperative details and outcome.
Total (n ¼ 58)
Median operation time, min (IQR) 98 (41)
Median contrast volume, ml (IQR) 150 (88)
Median blood loss, ml (IQR) 250 (350)
Median number of stentgrafts used, n (IQR) 2 (1)
Median covered aortic segment, cm (IQR) 22 (10)
Stentgraft type
Gore 42
Cook 4
Combined Gore þ Cook 3
Endoﬁt 3
Talent 2
Relay 1
Covered arteries without revascularization
Left subclavian 22
Coeliac 1
Covered arteries with revascularization
Left subclavian 5
Left common carotid 7
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comparison of two proportions. One-way ANOVA was used for
assessment of change in aortic diameter in patients with varying
extent of false lumen opaciﬁcation. Survival estimates and re-
intervention rate were assessed with KaplaneMeier life tables,
and are presented with standard errors (SE). Groups are compared
with Log-Rank test. A forced entry Cox proportional-hazards
regression model was used to assess the association of age,
gender, urgency of intervention, maximal aortic diameter pre-
intervention and increase in aortic size with mid-term mortality.
Missing values were handled with case deletion. A two-tailed
p-value of <0.05 was regarded as statistically signiﬁcant. Statis-
tical evaluation of the data was carried out with SPSS version 18.0
(IBM Corporation, Somers, NY).
Results
342 patients were treated with endovascular repair of thoracic
aortic pathology over the study period of whom ﬁfty-eight
consecutive patients were treated for chronic type B aortic dissec-
tion. Forty-nine (84%) were treated electively for asymptomatic
dilatation of the aorta, and nine (16%) urgently for symptomatic
disease (three ruptures, six aneurysms with chest pain). The mean
time between the acute dissection and treatment was 29 months
(SD31), Table 1. Four (7%) patientswere treatedbetween14days and
three months after the onset of type B dissection (3 urgent and 1
elective). The population demographics are presented in Table 1.
Perioperative outcome
Ten (17%) patients required supra-aortic vessel bypass prior to
stentgraft implantation (ﬁve carotidecarotid bypasses, two carotid-
carotid-subclavian bypasses and three carotid-subclavian bypasses),
and one patient required an iliac conduit. Perioperative details are
presented in Table 2. Adjunctive procedures were performed in
seven patients, and included distal aortic uncovered stent in one
patient (indication: compressed true lumen), and covered stents in
the right renal artery and the coeliac axis in one patient (indication:
distal re-entries). Chimney stents were implanted urgently in the
supra-aortic vessels perioperatively in three (5%) patients due to
compromised ﬂow in the brachiocephalic or common carotid
arteries; 1) brachiocephalic artery stent in a patient with partial
coverage of its origin, 2) brachiocephalic artery stent in a patient
with acute conversion of type B dissection to type A compromising
the brachiocephalic artery, 3) left common carotid artery stent inTable 1
Patient demographics.
Parameter Overall
(n ¼ 58)
Aortic
remodellinga
(n ¼ 24)
No
remodellinga
(n ¼ 23)
p-value
Mean age (SD), years 66 (11) 63 (12) 69 (11) 0.10
Mean chronicity (SD),
months
29 (31) 24 (31) 29 (26) 0.63
Maximum aortic
diameter (SD), cm
6.4 (1.3) 6.5 (1.3) 6.0 (1.3) 0.15
Elective : Urgent, n 49 : 9 22 : 2 17 : 6 0.14
Male : Female, n 48 : 10 18 : 6 20 : 3 0.46
Previous ascending
aortic repair, n
8 4 3 1
Previous abdominal
aortic repair, n
4 2 1 1
Type IIIA : Type IIIB, n 14 : 41 8 : 16 4 : 19 0.32
SD ¼ Standard deviation.
a Aortic remodelling was deﬁned as reduction in maximum descending aortic
diamater of >0.5 cm from pre-operative imaging to ﬁnal follow-up. In total, 47
patients had follow-up imaging and were included in this analysis.a patient with partial coverage of its origin. One patient required
a femoro-femoral cross-over graft. One patient with a previous
infrarenal stentgraft and left-sided iliac occlusion and femoro-
femoral cross-over graft required stenting of the right iliac artery.
However, the right iliac occluded perioperatively, and thrombec-
tomy was unsuccessful so an axillo-bifemoral graft was performed.
Of the twenty-two patients (38%) who had deliberate coverage of
the left subclavian artery without revascularisation, one developed
paraplegia after developing a perioperative retrograde type A
dissection with subsequent open repair, and one developed late
ischaemic arm symptoms requiring revascularisation. Perioperative
mortality and morbidity are presented in Table 3. Out of four (7%)
conversions to type A dissection, two occurred perioperatively and
two within 30-days of the primary repair. Three of these had Cook
Zenith TX2 (Cook Medical, Bjaeverskov, Denmark) devices with
proximal barb ﬁxation, and three had previous carotidecarotid
bypass with the proximal landing zone of the stentgraft in Ishi-
maru Zone 1 of the aorta. In total four patients were treated with
Cook Zenith stentgrafts implanted proximally in the aorta, and seven
patients were treated with stentgraft placement in Ishimaru Zone 1.
There was one in-hospital death in the urgent group (multiple organ
failure after aortic rupture) and two deaths in the elective group
(multiple organ failure due to multiple peri-operative embolisation;
chest infection after open repair of retrograde type A dissection),
giving an overall perioperative mortality rate of 5.2%.
Mid-term outcome
Overall actuarial survival estimate of the 58 patients was 89% at
1 year (SE 4.2%), 82% (SE 5.6%) at 2 years and 64% (SE 7.8%) at 3Table 3
Perioperative morbidity and mortality.
Complications and mortality N (total ¼ 58)
Paraplegiaa 1
Transient ischaemic attack 1
Lower limb ischaemia 1
Pneumonia 2
Multiorgan failure 1
Type A dissection 4
Immediately peri-procedural 2
Within 30 days post procedure 2
In-hospital mortality 3
Multiorgan failure 1
Continued leak (intervention for rupture) 1
Chestinfection after type A repair 1
a After conversion of Type B dissection to Type A and open repair.
Table 4
Postoperative details and outcome.a
Total
(n ¼ 47)
Re-interventions
Number of patients with re-intervention during follow-up
(after 30-days)
12
Mean time to ﬁrst re-intervention, months (SD) 15 (18)
Total number of re-interventions 17
Proximal extension 3
Distal extension 2
Relining 1
Renal covered stent 1
Subclavian embolisation 1
Subclavian revascularization 1
EVAR 4
Open abdominal aortic aneurysm repair, dissection related 1
Open thoracic or thoracoabdominal aortic repairb 3
Number of patients with
0 re-interventions 36
1 re-intervention 8
2 re-interventions 3
3 re-interventions 1
Remodelling and false lumen thrombosisc
Aneurysm size during follow-up
Increasing 8
Stable 15
Decreasing 24
False lumen thrombosis
Proximal stentgraft 44
Mid stentgraft 41
Distal stentgraft 38
Distal to stentgraft 19
Thrombosed false lumen at level of stentgraft 37
All false lumen thrombosed 18
SD ¼ Standard deviation.
a Excludes eleven patients with no follow-up imaging (3 perioperative deaths, 3
early deaths (1e6 months) with no postoperative imaging, 1 stentgraft extraction
after open Type A dissection repair, and 4 lost to follow-up).
b Conversions included.
c False lumen thrombosis deﬁned as lack of contrast enhancement on arterial
phase computed tomography.
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(39%) were not cardiovascularly related (ﬁve cancer, one respira-
tory failure, one gastrointestinal bleeding). Three (17%) deaths were
recorded as cardiac disease, three (17%) patients died a sudden
death with unknown cause, one (6%) died after open aortic repair
and one (6%) was diagnosed with rupture of the thoracic aorta at
post mortem. Data was not available in the remaining three (17%).
Forty-seven patients with follow-up imaging were included in
the analysis of mid-term outcome (mean follow-up 38 months, SD
28), Table 4. The estimated reintervention rate based on
KaplaneMeier analysis was 15% (SE 5%) at 1-year, 25% (SE 7%) at
2-years and 29% (SE 8%) at 3-years, Fig. 3. Re-interventions are
detailed inTable 4. Open thoracoabdominal repairwas performed in
three patients: 1) patient with a distal extension re-intervention
later required open repair with removal of the distal stentgraft 2)
due to continued distal pressurisation of the false lumen with sac
expansion and 3) due to continued expansion of the sac despite lack
of contrast enhancement in the false lumen. One of these patients
died perioperatively and one developed paraplegia. One additional
patient developedparaplegia during follow-up after re-intervention
with a proximal extension of the stentgraft and coverage of the left
subclavian artery without revascularisation. Both patients with
paraplegia had partial reversal of symptoms on insertion of a cere-
brospinal ﬂuid drain.
During follow-up, 51% (24/47) of the patients had a decrease in
the maximum diameter of the descending thoracic aorta, 32%
(15/47) had no signiﬁcant change (deﬁned as a change less than
0.5 cm) and 17% (8/47) had increased in size. Mean reduction in
maximal descending thoracic aortic diameter (comparison of the
pre-operative CT scan with the ﬁnal follow-up scan) was 0.7 cm
(SD 1.3), with mean change rate of 0.36 cm/year (SD 0.94). In 19
patients with more than three year follow-up, the aortic diameter
decreased in 12 (63%), was stable in 4 (21%) and increased in three
(16%). Aortic diameter increased in patients with no false lumen
thrombosis (assessed as the presence of contrast enhancement
during the arterial phase CT scan) or thrombosis only at one
measured level, and was reduced in patients with false lumen
thrombosis at three or four levels, Fig. 4. Total false lumen throm-
bosis (deﬁned as no contrast enhancement throughout the entire
length of the dissection) occurred in 38%, Table 4. Therewas no case
of visceral artery malperfusion due to false lumen thrombosis. OnlyFigure 2. KaplaneMeier analysis of survival after endovascular intervention for
chronic type B dissection.2/37 (5%) patients with false lumen thrombosis throughout the
length of the stentgraft experienced expansion of the aortic
diameter, compared to 4/10 patients (40%) of those with a patent
false lumen at the level of the stentgraft (p ¼ 0.01). Total falseFigure 3. KaplaneMeier analysis of reintervention rate after endovascular treatment
of chronic type B dissection.
Figure 4. Change rate in aortic diameter based on the extent of false lumen throm-
bosis (deﬁned as lack of contrast enhancement in the false lumen on arterial phase CT
imaging). False lumen thrombosis/patency assessed at 1) proximal, 2) mid, 3) distal
stentgraft and 4) distal to the stentgraft. Error bars represent standard deviations.
Table 5
Cox regression analysis of factors related to mortality in patients with mid-term
followup.
Parameters Odds ratio P-value 95% CI
Age, per year 1.08 0.04 1.00 1.17
Female vs male 0.01 0.03 0.00 0.64
Urgent vs elective 0.59 0.60 0.08 4.33
Maximal aortic diameter
pre-intervention, per cm
0.92 0.82 0.43 1.95
Increase in aortic size, per cm 2.70 0.01 1.23 5.96
CI ¼ Conﬁdence interval.
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IIIA dissections (83%) than type IIIB dissections (23%), p < 0.001.
Survival was assessed on the presence of aortic remodelling
during follow-up. Patient characteristics for the two cohorts is
presented in Table 1. Survival was higher in patients with aortic
remodelling compared to those with no remodelling, (3-year
survival estimate with aortic remodelling 89%, SE 7.2%; without
remodelling 54%, SE 13.8%; Log Rank p ¼ 0.005), Fig. 5. The survival
estimate at 3-years was inferior in patients with stable aortic
diameter (50%, SE 18%) when compared to patients with decreasing
aortic diameter (89%, SE 7.2%, Log Rank p ¼ 0.006). In the Cox-
regression analysis a one cm increase in aortic size during follow-
up was associated with an odds ratio of 2.7 for death (95% CI
1.23e5.96), Table 5.
Discussion
Endovascular treatment of chronic type B dissection has
acceptable perioperative morbidity and mortality. However mid-
term success with full exclusion of the false lumen remains a chal-
lenge despite re-interventions and was achieved in less than half
the cases in this series, which is consistent with previous reports.5,7
Mid-term survival in the current series for patients treated with
stentgraft for chronic type B dissectionwas discouraging, especially
in thosewith a lack of aortic remodelling on follow-up. The absence
of contrast enhancement in the false lumen on CT can act as
a surrogate marker of successful treatment,14 and was related to
aortic remodelling.Figure 5. KaplaneMeier analysis of survival based on remodelling of the aorta after
endovascular intervention for chronic type B dissection.The perioperative mortality of 5% in the current study is in range
of previous reports (0e7.5%)5e7,9 and is encouraging when
compared to open repair (14e30%).1e3 Neurological complications
were also acceptable. Themost frequent perioperative complication
in the current series was retrograde Type A dissection which
affected four patients. This is a well-recognised complication and is
presumably associatedwith the inherent fragility of the aorta in this
population. The current study underlines the increased risk of
retrograde type A dissection when the device is deployed in the
aortic arch. Due to the complexity and complication risks associated
with open aortic arch repair,15 the use of stentgraft in the aortic arch
is justiﬁed despite the increased risk of retrograde type Adissection.
Proximal bare stents and balloon dilatation of the stentgraft have
previously been associated with retrograde type A dissection.6,13 In
this report, three out of four patients treatedwith a device designed
with proximal barb ﬁxation developed retrograde type A dissection
within 30 days. Although it is not certain that the barb ﬁxation
caused the retrograde dissections in these patients, we currently
avoid using devices with proximal bare stents or barbs in aortic
dissection. The Cook Zenith TX2 devices used in this series pre-date
the introduction of the “Pro-Form” modiﬁcation, which increases
the conformability of the endograft to the aortic arch.16 Approxi-
mately one-third of patients required re-intervention in the follow-
up period in this study which is consistent with previous reports.5,6
Half of these occurred after the ﬁrst year of follow-up, indicating the
need for continued surveillance in these patients.
There are few reports of mid-term survival after endovascular
treatment of chronic type B dissection in the literature, but the
overall outcome is suboptimal.5 In the current study, survival was
signiﬁcantly lower in patients with no aortic remodelling, even
when correcting for age, gender and the urgency of repair in
a multivariate analysis. The mid-term survival was also poor in
patients with stable aortic diameter (change of <0.5 cm), and this
raises the question as to the timing of re-intervention in these
patients. Unfortunately, it was not possible to ascertain the precise
cause of death in several patients in this group and therefore we
cannot determine the relationship to aortic dissection. In addition,
concomitant disease and medications for which the analysis is not
corrected can be confounding factors. Potential explanations for
the high mortality include a high rate of renal or cardiovascular
comorbidity, uncontrolled hypertension contributing to sac expan-
sion and rupture, as well as failure to achieve complete depressur-
isation of the false lumen. Experimental data suggest that the size
and position of entry tears could potentially affect the outcome of
chronic type B dissection.17 There is some evidence that the pattern
of ﬂow in the false lumen is related to the rate of aortic expansion on
4D magnetic resonance imaging.18 Further studies could determine
whetheroptimisedmedical treatmentormore aggressive surgical or
endoluminal intervention could potentially improve the long-term
outcome in these patients. New methods for risk stratiﬁcation of
patients may be based not only on the anatomical distribution
of entry tears but also on functional information such as the pattern
of ﬂow in the false lumen.
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the treatment of aortic dissection is controversial. Traditionally,
patency of the false lumen was regarded as a negative predictor of
outcome.14 However, partial thrombosis has also been associated
with poor outcome when compared to complete or no throm-
bosis.19 Lack of contrast enhancement on arterial phase CT scan is
often described as false lumen thrombosis but this may not be true.
Arterial phase CT over-estimates the amount of false lumen
thrombosis signiﬁcantly,20 and is primarily an indicator of ﬂow
velocity in the false lumen rather than thrombosis. Delayed phase
CT may visualise thrombus more accurately. Recently, magnetic
resonance imaging has been used to assess ﬂow in the false lumen
pre- and post-intervention.20 In the current study, false lumen
patency was assessed relative to the position of the stentgraft
which covered the primary entry tear to achieve depressurisation.
The current study indicates that lack of false lumen contrast
enhancement on arterial phase CT due to reduced ﬂow often results
in aortic diameter reduction, and this can be a surrogate marker for
successful outcome. The low rate of complete false lumen throm-
bosis in Type IIIB dissections indicates the need for a change in
treatment strategy with long segment aortic coverage of all
signiﬁcant entry tears rather than just treatment of the primary
entry tear.
There are several limitations to the current study. Despite the
fact that this is one of the largest homogeneous series of patients
with endovascular treatment for chronic type B dissection with
mid-term follow-up,5e8 the limited number of the patients and the
loss to follow-up over time affects analysis of outcome. Multi-
variate analysis of data can be hazardous with this size of cohort.
Lack of data on the exact cause of death, comorbidities and medical
treatment makes interpretation of the poor mid-term survival
difﬁcult. Although assessment of aortic diameter was performed
prospectively with the observer blinded to the outcome, the reli-
ability of the measurements was not assessed. In assessment of the
rate of change in aortic diameter in different subgroups, the rela-
tively small number of patients per group as well as the assumption
of a linear growth rate of the aortic diameter can affect validity of
results. Further follow-up and amalgamation of data from different
centres can increase our understanding of how to best treat this
complex aortic pathology.Conclusions
Endovascular repair of chronic type B dissection is associated
with acceptable perioperative outcome, but mid-term success with
full exclusion of the false lumen remains a challenge. Mid-term
survival is signiﬁcantly related to a lack of aortic remodelling.
Change in aortic diameter during follow-up is related to the extent
of false lumen contrast enhancement on arterial phase CT scan.
New functional methods such as 4D magnetic resonance imaging
may help to more accurately risk stratify patients with chronic type
B aortic dissection.Conﬂict of Interest
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